The interferon-alpha signature of systemic lupus erythematosus.
about
Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLELinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusInflammatory cytokines in systemic lupus erythematosusJanus kinase inhibitors in autoimmune diseasesIntracellular nucleic acid sensors and autoimmunityStructural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosusThe deleterious role of basophils in systemic lupus erythematosusPattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseasePathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusConstitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.MicroRNA Regulation in Systemic Lupus Erythematosus PathogenesisFunctional correlations of pathogenesis-driven gene expression signatures in tuberculosis.Genomic signatures characterize leukocyte infiltration in myositis muscles.Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.Requirements for innate immune pathways in environmentally induced autoimmunity.Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case-control study.The periodontal pathogen Porphyromonas gingivalis changes the gene expression in vascular smooth muscle cells involving the TGFbeta/Notch signalling pathway and increased cell proliferationAGS, SLE, and RNASEH2 mutations: translating insights into therapeutic advancesThe dysregulation of cytokine networks in systemic lupus erythematosus.Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndromeComparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.Interferons in autoimmune and inflammatory diseases: regulation and roles.Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice.Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed miceEssential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus ErythematosusPopulation pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patientsSifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific DiseasesMultiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosusBiomarkers in systemic lupus erythematosus: challenges and prospects for the future.
P2860
Q26767511-6CC8D998-A74F-4B8E-9833-64938D95DE5DQ26822662-DCBB2DED-92C1-48D7-8D3D-B9BD57A3651DQ26823647-8F3B3385-171D-4C57-AFFF-194D71FE94DDQ26865446-14E299C9-FA3B-455D-9423-138F71DB01A3Q26997316-3BEC706C-65D7-4811-B5E0-43CEF8A2CD4AQ27677078-C7021A1F-0CFA-412E-B181-B72C5AE168BEQ27693310-DC0CC556-FB29-4C8C-94F4-4906FAAFADD8Q28084262-8E9BC68D-5737-4067-96C1-5835D3B79894Q28088753-39BDE7D3-0121-4132-B195-37792CEB5501Q31080044-ED1DEB0C-0D53-4B1F-AB02-E00D7BC0839FQ33682274-4B866646-DEE5-4A0F-96D0-DF5AE01F3D87Q33777950-6F8E2B20-006E-4BE5-86D4-CF038D11A2CEQ33838816-D3D2E4BB-ED7A-4626-B3EC-A8D05B290F38Q34064861-EBC12CAC-D179-4FC2-94A8-DEBB515B938AQ34484782-187968CB-8CB3-4189-87A4-DBAC38BECEA4Q34583337-D40E6391-502A-4E1E-A1D7-DE6F6B81671BQ34587471-10DB462A-FC03-4636-AC7F-1AF77031406FQ34655526-94F20EBE-F4C8-4A40-84C6-F184D23F0252Q34735179-CB7033CA-BFC2-4C55-85BB-D149F25F2266Q35037649-2CF1F4FC-234E-471B-A0F5-14B5CDF29D5DQ35242554-49F637DD-8265-43C3-A519-4C416C038183Q35294513-C57B245F-C700-485D-BFF8-1A6F0F7FF2E8Q35535151-DF22BF5B-3393-4A1E-B643-222A4772C9AAQ35544692-BAB715D3-5F01-4905-A426-29B73A467C5AQ35603598-E335F64D-661F-43F6-BA08-2579D6CD9791Q35685720-307B2FA9-89BC-4EE8-8B39-2E60635D3917Q35724900-9FEA6E22-7094-40E7-A916-CE11F6D69B5FQ35743904-4075EAA5-50B4-404C-8662-66CAB717BDA9Q35791280-0BCF76DF-64A9-45A3-A3CE-E7CA8DCB5C54Q36040281-3E837997-7DA2-457C-AA4F-E41F50F5D8B1Q36111739-16B493D9-5879-4984-8303-00120D800DACQ36377207-5CEE10E4-9BE4-4083-9C1D-D3017529500FQ36490737-51953652-3B54-42E8-9B60-2ACB8C25A794Q36637528-43C85A24-CA62-4396-BBB2-B85C9AC6394BQ36718239-69D4C041-85C9-4255-87E8-BFC5ECA25417Q36806646-2673ED08-8BBA-47F5-99C7-CD88E206EBC6Q36844513-1CB11ABD-B459-4D93-BA68-3D7537FA97EDQ36983628-D2B97DED-AF27-4B22-B0DC-AD6024BBAA27Q36985980-EAABE1FF-44C9-4F82-92B8-257B220C57E8Q37058781-BB804F0C-7206-4709-AEFB-E4236F339FA0
P2860
The interferon-alpha signature of systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The interferon-alpha signature of systemic lupus erythematosus.
@en
type
label
The interferon-alpha signature of systemic lupus erythematosus.
@en
prefLabel
The interferon-alpha signature of systemic lupus erythematosus.
@en
P2860
P356
P1433
P1476
The interferon-alpha signature of systemic lupus erythematosus.
@en
P2093
G Obermoser
P2860
P304
P356
10.1177/0961203310371161
P577
2010-08-01T00:00:00Z